Stay updated on Pilot Trial Flecainide in ARVC Patients Clinical Trial
Sign up to get notified when there's something new on the Pilot Trial Flecainide in ARVC Patients Clinical Trial page.

Latest updates to the Pilot Trial Flecainide in ARVC Patients Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov record for a completed pilot trial of flecainide in patients with arrhythmogenic right ventricular cardiomyopathy is displayed, including its study design, eligibility criteria, outcomes, locations, and documents.SummaryDifference57%

- Check9 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check16 days agoChange DetectedA sitewide notice announces an NIH transition from “Artificial Intelligence” to “Super Intelligence” terminology and links to transition updates and FAQs.SummaryDifference1%

- Check23 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check30 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe study record area displays a 403 Forbidden message with a Home link instead of study details.SummaryDifference0.5%

Stay in the know with updates to Pilot Trial Flecainide in ARVC Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pilot Trial Flecainide in ARVC Patients Clinical Trial page.